>> Black Swan Analysis Blog

Black Swan Analysis Blog

NICE deems Rubraca® cost effective for the NHS to treat Ovarian Cancer

On October 22, 2019, Tags Pricing Strategies, Gene Therapy, Medicine

As of October 11th, Rubraca (Rucaparib) has been approved for NHS use by NICE in its final draft guidance (NICE, 2019). The drug, developed by the University of Newcastle, will benefit women with...

The health implications of e-cigarettes

On October 14, 2019, Tags Medicine

As the scientific understanding and awareness of the detrimental effects smoking tobacco has on the lungs has grown, it has concurrently led to an increase in cigarette substitutes in order to...

A New Era of Contraception

On July 18, 2019, Tags Medicine

With an ever-growing societal attitude of equality and the push forward towards feminism, there is a desire for the development of a male contraception in order to have both individual and shared...

Challenges surrounding CNS drug discovery

On July 11, 2019, Tags Medicine

The central nervous system (CNS) compromises the brain and spinal cord and is the most complex system in the human body; consisting of an estimated 100 billion neurons, each connected to thousands...

The Opioid crisis in North America

On June 27, 2019, Tags Medicine

Opioids are the most commonly prescribed medications to manage chronic pain. They work by lowering pain signals the body sends to the brain, they also alter how the brain would react to pain. Opioids...

Challenges Of Changing Clinical Guidelines To A Patient Driven Market Forecast

On February 11, 2019, Tags Medicine


Patient-based forecast models follow patient cohorts through a framework which is the forecasters best understanding of a markets dynamics at a given time. Each forecast tells a story through...

Amazon’s Healthcare Push - Moving Forward with Digital Healthcare

On January 24, 2019, Tags News, Newsletters, Medicine


The Centers for Medicare & Medicaid Services (CMS) recorded $3.5 trillion in National Health Expenditures (NHE) in 2017 which accounts for 17.9% of the U.S. GDP, and projected the NHE to...

Abilify Mycite - A new breed of digital innovation?

On January 15, 2019, Tags News, Medicine

Abilify MyCite was approved in November 2017 by the FDA. The medication contains aripiprazole with an ingestible sensor that digitally tracks whether the patient has taken it. It aims to address...

Data driven medicine is patient-centred medicine

On December 19, 2018, Tags Medicine

Artificial intelligence (AI) refers to intelligence demonstrated by technology rather than human intelligence. It is used in many platforms ranging from business sectors to educational...

New Call-to-action

Subscribe to Email Updates

New call-to-action
RX Brochure CTA Large

Recent Posts

Free Brochure Epiomic